drugset / Trial / NCT00422110

A Study to Evaluate the Efficacy and Safety of Seletracetam in Adult Patients With Refractory Partial Onset Seizures

NCT00422110 ↗

Phase 2/3 Withdrawn UCB Pharma
RandomizedParallel-groupDouble-blindTreatment

Summary

This study will evaluate the effectiveness and safety of seletracetam when it is used in addition to other anti-epileptic medications by patients with partial onset seizures. It will also help to determine the best dose to use.

Timeline

Start
2008-05
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Seletracetam Small molecule — —

Indications